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Abstract 
With the widespread presence of sleep disorders in the United States, especially 
insomnia, it is pertinent to investigate beliefs that patients have about insomnia, symptom 
severity, and treatment acceptability in order to assess patients’ motivation for behavioral 
change. Participants in this archival study were thirty-one patients seeking help for sleep-
related issues, whom were primarily from a Midwestern metropolitan area. Patients had 
completed pre-treatment measures that assessed insomnia symptoms, outcomes, 
treatment acceptability, and willingness to change and one post-treatment measure 
assessing insomnia outcomes. Because the purpose of the present study was to examine 
whether these variables predict patient improvement (higher scores on the post-treatment 
measure), a linear regression was used to analyze the data. Results indicated that pre-
treatment insomnia outcomes, symptoms, change, and treatment acceptability did not 
predict higher scores of patient improvement. Because there has not been a significant 
amount of research conducted on the topic of predictors of insomnia treatment outcome 
and the fact that novel outcome measures were used, future research should focus on 
developing more psychometrically sound outcomes measures. 
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INSOMNIA PATIENT IMPROVEMENT      1 
    
Symptom Severity, Treatment Acceptability, and Motivational Predictors Related to 
Patient Improvement for Insomnia 
 In the United States today, sleep disorders and exiguous sleep quality is becoming 
a national pandemic. According to the Center for Disease Control (CDC), 50 to 70 
million Americans suffer from sleep disorders that cause wakefulness, such as insomnia. 
Sleep disorders like insomnia can create issues with everyday functioning (“Insufficient 
sleep”, 2014). For insomnia specifically, the National Sleep Foundation reports that 
almost 50% of the American population experiences insomnia every now and again, 
while 22% of the population suffers from insomnia almost every day of the week. Within 
the U.S. population, “females are 1.3 times more likely to report insomnia than males. 
Also, those over the age of 65 are 1.5 times more likely to complain of insomnia than 
younger people. Divorced, widowed and separated people report more insomnia” (“Sleep 
aids”, 2013). 
 While examining the symptomatic spectrum of insomnia effects, areas of life 
commonly disrupted by insomnia can range anywhere from difficulty concentrating and 
trouble with remembering things to more hazardous consequences such as having driving 
skills affected or struggling to perform occupational duties. Also, those who experience 
inadequate sleep are more apt to be affected by other abiding syndromes such as 
“hypertension, diabetes, depression, and obesity, as well as from cancer, increased 
mortality, and reduced quality of life and productivity” (“Insufficient sleep”, 2014). Not 
only does insomnia cause problems for each individual suffering from the disorder, but 
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the United States also suffers from insomnia as a whole, economically speaking. The 
most recent yearly update on the direct costs of insomnia’s effect on the United States’ 
population equaled more than 14 billion dollars. These costs include treatment for 
insomnia and other healthcare costs, such as doctors’ visits and hospital stays. Lastly, 
besides the direct cost of insomnia symptoms to the U.S. healthcare system, the indirect 
costs of insomnia reach up to 35 billion dollars annually and the cost of productivity lost 
to insomnia alone is approximately equal to 18 billion dollars a year (National Sleep 
Foundation, 2013). 
 With the widespread presence of sleep disorders in the United States, especially 
insomnia, it is pertinent to investigate beliefs that patients have about insomnia, symptom 
severity, and treatment acceptability in order to assess patients’ motivation for behavioral 
change that can lead to overall improvement. Recent empirical literature has examined 
these very topics. For instance, Montserrat Sánchez-Ortuño and Edinger (2010) 
conducted a study that investigated the relationships between patients’ maladaptive 
beliefs about insomnia, their presenting symptoms, and treatment progression. This study 
used a sample of over 250 insomnia patients and had the patients complete the 
Dysfunctional Beliefs about Sleep questionnaire (DBAS-16). After completing this scale, 
patients also completed an Insomnia Symptoms Questionnaire (ISQ), the Stanford 
Sleepiness Scale (SSS), the Beck Depression Inventory (BDI), the State-Trait Anxiety 
Inventory (STAI), and, lastly, a sleep history questionnaire.  
 Overall, the results from the DBAS-16 were aggregated into four distinct 
subgroups, according to the patients’ scores on the questionnaire itself. These subgroups 
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were labeled as the “Worried and Medication-Biased” cluster, the “Low Endorsement” 
cluster, the “Mild Sleep Worries” cluster, and the “Worried and Symptom-Focused” 
cluster. Out of these subgroups, Montserrat Sánchez-Ortuño and Edinger (2010) noted 
that the “Low Endorsement” cluster held beliefs about sleep-related symptoms that would 
constitute an average individual’s beliefs with relatively low sleeping problems 
altogether. In general, two of the subgroups showed elevated scores in relation to 
insomnia symptoms, while the others were more representative of a “normal” sample 
(Montserrat Sánchez-Ortuño and Edinger, 2010). Subsequent to the completion of all of 
the questionnaires, the authors of the study conducted a Cognitive-Behavioral Therapy 
(CBT) program for the participants, with the number of treatment sessions spanning over 
one to eight weeks in length. All in all, the results of the study demonstrated that because 
of the differing and negative beliefs about insomnia amongst participants, one standard 
type of CBT treatment administration does not produce adequate treatment outcomes. 
These results suggest that CBT programs for insomnia should be specifically tailored to 
the individual in regards to their beliefs about sleep and their beliefs about treatment 
methods for overcoming insomnia (Montserrat Sánchez-Ortuño and Edinger, 2010).  
 Another study conducted by Sidani, Miranda, Epstein, Bootzin, Cousins, and 
Moritz (2009) examined individuals’ personal beliefs about insomnia. Although similar 
in nature to the study authored by Montserrat Sánchez-Ortuño and Edinger (2010), this 
study specifically analyzed the relationship between personal beliefs, treatment 
acceptability, and preferences for behavioral interventions. Sidani, et al.’s (2009) analysis 
used data from over 400 individuals with insomnia that participated in one of two clinical 
INSOMNIA PATIENT IMPROVEMENT           4 
trials that targeted treatment options for insomnia. During these clinical trials, 
participants were presented with treatment options for insomnia and were asked to rank 
these treatment options according to the acceptability of such methods and their 
preferences for the treatment options prescribed to them. The treatment options that 
participants were given included sleep education and hygiene or a multi-component 
intervention that included the education component, but also included stimulus control 
features and sleep restriction therapy to establish a regulated sleep-wake schedule.  In 
addition to preferences and treatment acceptability, demographic, clinical, and personal 
belief information was recorded for each participant as well.  This information was 
recorded in order to prevent confounding effects for each participant’s preferences for 
insomnia treatment.  
Comprehensibly, the results of Sidani, et al.’s (2009) investigation of beliefs 
about insomnia demonstrated that participants with persistent or chronic insomnia 
symptoms preferred behavioral interventions for the treatment of insomnia because of its 
lack of side effects and hope for long-term insomnia maintenance. Although behavioral 
interventions were preferred by a few patients, they would choose the most convenient 
method of treatment as the most preferable treatment, regardless of other types of 
treatment methods available, . Also, as the current study plans to expound upon treatment 
acceptability, Sidani’s (2009) findings display a predictive relationship between patients’ 
acceptability and beliefs about treatment and their preferences for treatment in general. 
Although the patients’ acceptability of certain treatment predicted and helped to guide 
their preferences toward certain treatments, the results of the study indicated that there 
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was not a relationship between the patients’ personal beliefs about insomnia, the 
condition itself, and their treatment preferences.   
 When continuing to evaluate the impact that insomnia has on a given population, 
it is imperative to measure patient preferences and acceptability of insomnia treatment 
methods in conjunction with their history of insomnia symptoms. As highlighted by 
Epstein, et al. (2012), specific methods of insomnia treatment, such as Cognitive 
Behavioral Therapy for Insomnia (CBT-I), have demonstrated to be highly efficacious in 
modern empirical literature, however, it is important to note how crucial patient 
motivation and willingness to accept treatment play apart in overall patient improvement. 
Treatment programs like CBT-I are usually very time-consuming and require patients to 
put forth a great deal of effort. If patients are not motivated enough and do not “have their 
hearts” in the treatment being provided, whether or not the method of treatment is 
“proven” to be effective, then the ultimate outcome for patients could be disappointing, at 
best (Epstein, 2012).  
 Another interesting finding to consider from Eptein’s (2012) study was the fact 
that clinicians and patients held significantly different attitudes and views towards the 
acceptability and preference of certain insomnia treatment. For instance, as mentioned 
above, many patients, especially in the case of this study with Veterans, participants felt 
that medications were the most acceptable form of treatment and were the most preferred 
method for symptom improvement. However, although providers rated medication highly 
as well, they differed in that they viewed sleep restriction practices and stimulus control 
therapies as better alternatives for overall insomnia improvement due to their empirical 
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effectiveness. Veterans tended to shy away from these methods of treatment due to their 
time-consuming nature and required effort. Both the clinicians and Veterans agreed that 
medication could create negative long-term effects, such as chemical reliance on the 
medication. Overall, the study found that most patients found the treatments they 
preferred the most to be the treatments that deemed as most acceptable.  
 When patient improvement is assessed in terms of treatment acceptability and 
willingness to change, some researchers have examined how patients perceived and 
viewed their own insomnia symptom improvement after a structured six-component CBT 
treatment program, which was the case in Vincent, Penner, and Lewycky’s (2006) 
groundbreaking study. Other studies have merely focused on the effectiveness of 
behavioral treatments or the preference levels and motivational factors related to 
treatment acceptability. However, very few have investigated how patients feel about 
their improvement, which could provide important information as to how and why 
patients felt that their symptoms improved throughout their treatment process.  
 Vincent, Penner, and Lewycyk (2006) demonstrated that certain aspects or 
characteristics of sleep itself are predictors of patients’ perceived symptom improvement. 
The Clinical Global Improvement Scale (CGI) was utilized during the course of this 
study and researchers allocated patient responses into two different categories of 
“primary” and “secondary” measures of sleep characteristics. Such primary measures 
include sleep characteristics of: sleep quality, sleep duration, and sleep efficiency. On the 
other hand, secondary measures included characteristics like daytime impairment (due to 
insomnia symptoms) and mood (Vincent, Penner, & Lewycyk, 2006). In general, it was 
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found that daytime impairment predicted better-perceived improvement and mood 
predicted a dearth of perceived improvement for secondary measures. For primary 
measures, sleep quality and duration were the strongest predictors of improvement. Due 
to the significant findings of prediction for the primary measures, understanding patients’ 
treatment acceptability ratings and motivations for treatment may help to better 
individually tailor a treatment program to best suit patients, rather than using the standard 
CBT-I protocol for all patients regardless of their clinical presentation. 
Purpose of the Current Study 
 Considering the research that has been conducted in this area of sleep psychology, 
the purpose of the present study was to determine whether the variables of insomnia 
symptoms, treatment acceptability, and behavior change factors affect patient 
improvement. Specifically, it was hypothesized that insomnia patients with more severe 
symptoms, that had high ratings of treatment acceptability across a wide array of 
treatments, and were motivated for changing their behavior would show greater 
improvements in insomnia symptoms at post-treatment. Specifically, improvement would 
involve endorsing a greater number of nights per week receiving enough quality sleep 
according to the post-treatment follow-up Insomnia Outcomes Scale used. Also, it was 
hypothesized that patients who improved over the course of the study would endorse a 
greater number of days per week that they were happy with how they felt and endorse 
fewer number of days per week in which they felt tired or fatigued.  
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Method 
Participants 
 There were 85 participants recruited for the present study at sleep centers in a 
large metropolitan area in the Midwestern United States. Other demographic information 
was not collected from participants to protect their privacy and participants were simply 
assigned random identification number. Participants were recruited during an initial 
appointment with a sleep psychologist to address ongoing symptoms of potential sleep 
disorders. Participants then attended a series of appointments with the sleep psychologist 
as prescribed by their treatment plan. At the conclusion of the study, a total of 31 patients 
were included in the analysis because the study required a measure of post-treatment 
symptoms and 54 of the original patients recruited did not complete the post-treatment 
insomnia symptoms measure.  
Measures 
 Insomnia outcomes scale. Dr. Donald Townsend at Fairview Health Systems in 
Minnesota developed the Insomnia Outcomes Scale. This scale includes four questions 
regarding the severity of insomnia symptoms in terms of how many nights per week the 
patient got enough sleep, how many nights per week the patient slept well, how many 
days per week the patient felt tired or fatigued, and how many days per week the patient 
was happy with how he or she felt. All of these items had a Likert-style response scale 
ranging from “1 or less” to “7” and referred to the nights or days per week that patients 
experienced symptoms within the past month (see Appendix A). One of the items on the 
Insomnia Outcomes Scale was recoded due to negative wording (“In the past month, how 
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many days a week have you felt tired or fatigued?”). Because the Insomnia Outcomes 
Scale is a newly developed measure of insomnia-related consequences, psychometric 
properties of the scale have not been tested. The present researcher conducted a 
preliminary reliability analysis and found the reliability of the questionnaire to be α = .78.  
 Treatment acceptability scale. The Treatment Acceptability Scale was also 
developed for clinical and research purposes by Dr. Donald Townsend. This measure 
consists of ten items describing ten different methods of insomnia treatment. These 
treatment methods include behavior modification treatment methods (relaxation CD, 
changing my sleep habits, reading a book about sleep, stop using caffeine, alcohol, and 
tobacco products, and getting out of bed if the patient cannot sleep), medication treatment 
(prescription medication and over-the-counter medication), and medical expert 
professional treatment (talking to my primary care physician, talking with a 
counselor/therapist, and seeing a sleep therapist). Items on the treatment acceptability 
scale have a Likert-style response scale with responses ranging from “Not effective at 
all” to “Highly effective” (see Appendix B). A reliability analysis was also conducted for 
this measure, with α = .80.  
 Change scale. The Change Scale was also developed by sleep psychologist Dr. 
Donald Townsend for clinical and research purposes. This scale includes eleven items on 
a 1 to 5 Likert scale with responses ranging from Strongly Agree (1) to Strongly Disagree 
(5). Items on the scale captured patients’ motivation to change behaviorally in regards to 
their insomnia symptoms and personal characteristics (see Appendix C for specific scale 
items). Five of the items on the Change Scale were recoded in order to account for their 
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negative wording (“My sleep problems are not that important.”, “I’ve given up on trying 
to improve my sleep problems.”, “It is very difficult for me to make changes in my life.”, 
“I don’t think there is anything I can do to improve my sleep problems.”, and “Most of 
what happens to me is bad luck.”). Because the Change Scale is a newly developed 
measure and has not yet been psychometrically tested, a reliability analysis of the scale 
was conducted, demonstrating results of α = .46. 
Procedure  
 Patients whom presented with or complained of symptoms of insomnia were 
asked if they would like to participate in the current study at their first appointment with a 
sleep psychologist. Data collected for the current study was archival data that was 
originally used to assess the use of an insomnia outcomes scale. In order to participate in 
the study, patients had to give consent for participation in the study and for treatment by 
signing a detailed consent form (see Appendix D). Patients also received a recruitment 
flyer at the time of consent in order to provide an outline of the requirements of the study 
(see Appendix E). Participants who had consented to participating in the study were 
subsequently given the Insomnia Outcomes Scale, the Treatment Acceptability Scale, and 
the Change scale to complete. Responses to each of these questionnaires were recorded 
and organized into a Microsoft Excel spreadsheet and then were later transferred to the 
Statistical Package for the Social Sciences (SPSS) for further data analysis. Data that was 
missing in SPSS was labeled as missing with the response, “999”.  
 Six months after the initial appointment when the original questionnaires were 
completed, participants were mailed another copy of the Insomnia Outcomes Scale to 
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complete as a post-treatment follow-up questionnaire. If patients did not return the 
follow-up Insomnia Outcomes Scale to the sleep clinic via the postage-paid envelope 
given to them within a month of receiving the questionnaire, then a second copy of the 
questionnaire was sent. When patients did respond either of the copies of the follow-up 
questionnaire that was sent, a last reminder was given to patients of whom patients were 
contacted via telephone. If a patient responded on the telephone, the follow-up Insomnia 
Outcomes Measure was administered to the patient during the telephone call, as was 
stipulated by a standardized procedure of greeting the patients, administering the 
questionnaire, and finally, concluding the call by welcoming any patient comments about 
their experiences with treatment for insomnia.  
 Once data was gathered from the follow-up outcomes measure, it was entered into 
the SPSS database. However, as mentioned previously, data from 54 of the participants 
was excluded from data analysis because they did not complete the post-treatment 
Insomnia Outcomes Scale measure.  
Data Analysis 
 Because the hypothesis of this study proposes that responses on the initial 
Insomnia Outcomes Scale, Treatment Acceptability Scale, and the Change Scale predict 
overall patient improvement (as indicated by higher levels of responding on the post-
treatment follow-up Insomnia Outcomes Scale), a multiple linear regression analysis 
approach was used to test the hypothesis. For data analysis purposes, the Treatment 
Acceptability Scale was divided into three groups based upon the item type, resulting in 
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three treatment acceptability variables: “Medication Treatment”, “Behavior Modification 
Treatment”, and “Medical Expert Professional Treatment”.  
Results 
 With the data remaining from the 31 participants who completed the follow-up 
Insomnia Outcomes Scale, a multiple linear regression was conducted. The initial 
Insomnia Outcomes Scale, the Treatment Acceptability Scale variables (“Medication 
Treatment”, “Behavior Modification Treatment”, and “Medical Expert Professional 
Treatment”), and the Change Scale were used as predictors in the regression model, while 
the follow-up Insomnia Outcomes Scale was used as the criterion. To conduct the 
regression analysis, the pre-treatment variables (the four items on the questionnaire, 
utilizing the recoded item) of the Insomnia Outcomes Scale were combined together to 
compute a new variable, as were the post-treatment variables (the four items on the 
questionnaire, utilizing the recoded item) of the follow-up Insomnia Outcomes Scale in 
order to create a measure of both pre- and post-treatment outcomes. Similarly, the eleven 
variables, or items, on the Change Scale (utilizing the five recoded items) were combined 
to create a new variable of the scale’s responses as a whole.  
 The results of the multiple linear regression analysis demonstrated that the overall 
model of the study’s hypothesis was non-significant, where F(5, 26) = 1.27, p > .05 (see 
Figure 1 in Appendix F). Because the overall model was non-significant, the individual 
predictors were non-significant as well (see Table 1 and Table 2 in Appendix F). 
However, the pre-treatment Insomnia Outcomes Scale was marginally significant at β = 
.42, p = .06.  
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 In addition to the multiple linear regression, a one-way repeated measures 
ANOVA was conducted to assess the differences between the pre-treatment insomnia 
outcomes measure and the post-treatment insomnia outcomes measure. This analysis was 
conducted because the results within the regression model for prediction between these 
two variables were marginally significant. The results of this analysis demonstrated non-
significant results, F(13, 27) = 1.01, p > .05. This result indicates that there are no 
significant differences between responding on the pre- and post-treatment insomnia 
outcomes measures, suggesting that the functioning of patients in regards to their 
insomnia symptoms did not significantly improve.  
 Also, it is imperative to note the variance in responding on the various measures 
used for this study as well. For the pre-treatment insomnia outcomes measure (M = 9.32, 
SD = 5.33), the post-treatment insomnia outcomes measure (M = 17.35, SD = 6.90), the 
medication treatment acceptability subscale (M = 35.18, SD = 178.88), the medical expert 
professional treatment acceptability subscale (M = 35.18, SD = 178.88), and the change 
scale (M = 33.30, SD = 3.57), the variance amongst the data of responding was relatively 
large, as indicated by higher standard deviation scores. This indicates that the data for 
these measures does not accurately represent the mean. However, the behavior 
modification treatment acceptability scale (M = 2.34, SD = 0.79) had lower variance in 
responding and includes data that more accurately represents the mean. This result could 
suggest that behavior modification treatments were perceived as more acceptable to 
participants of this study, compared to other treatment options.  
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Discussion 
 Although previous research in the area of sleep psychology has demonstrated that 
patient improvement is dependent on an individual’s insomnia symptoms, willingness to 
change, and treatment acceptability, the present study failed to demonstrate similar 
results. In this case, insomnia outcomes and symptoms, willingness to change, and 
treatment acceptability did not predict patient improvement.  
 The non-significant findings of this study can be understood in terms of 
limitations of the study’s design and use of measures with unknown psychometric 
properties. One of the greatest limitations of this study concerns the small sample size. 
Original recruitment efforts at the sleep clinic resulted in an initial pool of 86 
participants. But, with the low response rate of participants for the post-treatment 
Insomnia Outcomes Scale at 36%, only 31 participants were included in the study. 
According to Hager, Wilson, Pollak, and Rooney (2003), the acceptable rate of survey 
responses for a study varies within different fields of research, ranging anywhere from as 
low as 50% to as high as 75%. Some researchers even suggest that response rates below 
than 60% are atrocious (Schutt, 1999). By these standards the response rate for the 
current study was relatively low, which calls into question whether a representative 
sample was obtained for this study.  
In addition, response bias may pose a limitation in that certain individuals are 
simply more likely to respond to mailed surveys than others, which also limits the 
representativeness of the sample. Lastly, although the post-treatment outcomes measure 
was sent to participants twice and a standardized phone call was used to follow up, 
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variables such as not having the envelopes addressed using handwritten words, not 
having a real stamp on the envelope (instead of a pre-paid business reply postage), or not 
having any monetary incentive for the completion of the questionnaire could have 
negatively affected the response rate (Hager, et al., 2003).  
 Besides addressing the importance of the study’s sample size in terms of 
acceptable response rates, it is vital to address the role of sample size and how it relates to 
the power of this study. With such a low sample size, the power of the current study is 
only at a 0.71 level (calculated using the statistical software, G*Power). In most cases, a 
.80 level of statistical power is deemed appropriate for a study (Field, 2013). Because 
sample size affects the level of power for data analyses (because it is difficult to discover 
effect sizes within smaller populations), a lower level of power can impact significance 
levels in deleterious ways, such as failing to detect effects that are present.   
 Another limitation of the current study includes the significance of the pre-
treatment Insomnia Outcomes Scale in the regression analysis. Although the overall 
model for the regression used in this study was found to be non-significant, the 
marginally significant result for the pre-treatment Insomnia Outcomes Scale potentially 
indicates that pre-treatment functioning of patients predicts overall post-treatment 
improvement. For example, higher ratings on the pre-treatment Insomnia Outcomes Scale 
would predict lower endorsement ratings on the post-treatment Insomnia Outcomes 
Scale. However, the results of the one-way ANOVA test in this study demonstrate that 
there were no significant differences between these two variables. It is possible that the 
marginally significant results occurred due to chance. With that being said, one factor 
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that could potentially influence the significance of this outcome is the small sample size 
in this study. Future studies with larger samples may find significant relationships 
between pre-treatment and post-treatment insomnia outcomes.   
 The lack of significant results could also possibly be explained by the 
psychometric properties of the scales and questionnaires used. For instance, because the 
three measures used in the study were recently developed, they have yet to be 
psychometrically tested. As mentioned previously, the reliability of the scales were 
analyzed, however one measure, the Change Scale, had an unacceptable Cronbach’s 
alpha value of α = .46. Because the reliability for this measure was low, there should be 
caution when using it to evaluate patient improvement for individuals experiencing 
insomnia. Also, because there is a lack of psychometric data available for these three 
scales, it is highly recommended that future research assess their validity before using 
them in primary care settings, given that utilizing these measures in primary care was the 
original intent in their creation. 
  In regards to the construction of the measures themselves, it is suggested that the 
actual construction of individual items be revisited for future use. For example, many 
items within the instruments are “double-barreled” with more than one query in each 
item, such as “Stop using caffeine, alcohol, and tobacco products”. The problem with 
“double-barreled” items is the fact that participants may choose their response based on 
one part of the item, instead of all parts of the item. In this instance, a participant may 
choose “Strongly agree” if they use caffeine and alcohol, but this neglects to address 
tobacco products in the item if the participant does not use tobacco.  Also, participants 
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may have difficulty differentiating between scale anchors. For example, in the Treatment 
Acceptability Scale differences between anchors such as “Slightly Effective”, “Unclear 
Effectiveness”, and “Moderately Effective” may be difficult for respondents to 
distinguish. To subjectively quantify the difference between whether a treatment is 
slightly effective or moderately effective may prove to be an arduous task. Lastly, 
because participants completed the Treatment Acceptability and Change questionnaires 
during the same period of time, the response scales may have created incorrect 
responding because the response scales were opposite of one another. In other words, the 
Treatment Acceptability measure uses the first anchor as the most negative response 
(“Not Effective at All”) and the Change Scale uses the first anchor as the most positive 
response (“Strongly Agree”). From a visual perspective, the left to right placement of 
anchors being opposite from one questionnaire to the next may have enabled erroneous 
responding on behalf of participants.  
 Results of the current study demonstrated that pre-treatment insomnia outcomes, 
treatment acceptability, and motivation for change did not predict improvement for 
patients’ insomnia outcomes. These results can be accounted for by numerous limitations 
such as a low response rate, small sample size, low power, and weak psychometric 
properties of some measures. Future research should focus on refining test construction 
of the three measures used as well as working to increase the sample size to provide a 
more robust test of the study’s hypothesis.   
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CONSENT FORM 
Using a Computerized Self-Report Questionnaire to 
Assess Sleep Disorders Presenting with Insomnia Symptoms 
You are invited to join in a research study examining the usefulness of a questionnaire to 
help diagnosis symptoms of insomnia. You were selected as a possible participant 
because you described symptoms of insomnia, which include difficulty falling to sleep, 
frequent nighttime awakenings sometimes with difficulty falling back to sleep, waking 
too early and inability to return to sleep or feeling as though your sleep is poor quality.  
We ask that you read this form and ask questions before agreeing to be in the study. 
This study is being conducted by: Don Townsend, PhD, Con Iber, MD, Louis Kazaglis, 
MD, from Fairview Health Systems and Shelby Afflerbach, BA of Minnesota State 
University, Mankato. 
 
Background Information 
 
The purpose of this study is to determine whether a brief questionnaire that inquires about 
various symptoms of insomnia can differentiate between different causes of insomnia.   
 
Procedures: 
If you agree to be in this study, we would ask that you complete a short, computerized 
questionnaire in the office today and then again on the internet in about 2 weeks.  The 
questionnaire should take about 10 minutes to complete.   
 
Risks and Benefits of being in the Study 
 
The risks involved in this study are that you may feel uncomfortable answering questions 
about your problems with insomnia.     
There are no direct benefits to you for your participation.  Your assistance will help us 
learn whether this type of questionnaire can help distinguish between different sleep 
problems that may look like insomnia but that need a different type of treatment.   
 
Compensation: You will not receive any payment for participation in this study.   
Confidentiality: 
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The questionnaire is completed on the computer and your responses are stored on a 
secure server.  The only link between your name and the questionnaire is a unique ‘study 
number’ assigned to you during participation.  The reason we need your name and email 
address is to send you an Internet link to complete the questionnaire a second time while 
you are at home in about two weeks.  We need to be able to match the two questionnaires 
that you have completed.  Any report we might publish from this information will not 
include anything that will make it possible to identify you. Research records will be 
stored at Fairview Sleep Clinics in a password-protected file and only researchers will 
have access to the records. Study data will be stored on a secure server according to 
current University policy for protection of confidentiality. 
Voluntary Nature of the Study: 
Participation in this study is voluntary. Your decision whether or not to participate will 
not affect your current or future relations with Fairview Health System or the University 
of Minnesota. If you decide to participate, you are free to withdraw at any time without 
affecting those relationships.  
Contacts and Questions: 
The researchers conducting this study are: Don Townsend, PhD, Con Iber, MD, Louis 
Kazaglis, MD, and Shelby Afflerbach, BA. You may ask any questions you have now. If 
you have questions later, you are encouraged to contact Dr. Townsend at the Fairview 
Brooklyn Park office at (763) 528-6985, (507) 398-5518 or with email at 
dtownse4@fairview.org.  
If you have any questions or concerns regarding this study and would like to talk to 
someone other than the researchers, you are encouraged to contact the Research 
Subjects’ Advocate Line, D528 Mayo, 420 Delaware St. Southeast, Minneapolis, 
Minnesota 55455; (612) 625-1650. 
You will be given a copy of this form at your request. 
Statement of Consent: 
I have read the above information.  I know that I will not receive payment or 
compensation for my participation in this study.  I have had a chance to ask questions and 
had my questions answered. I consent to participate in the study.  
Participant Signature: ______________________________ Date: _____________ 
Office Staff Signature: ______________________________Date: _____________ 
Signature of Investigator: ____________________________Date: _____________ 
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Using a Computerized Self-Report Questionnaire to 
Assess Sleep Disorders Presenting with Insomnia Symptoms 
Primary Investigators: Don Townsend, PhD and Con Iber, MD 
 
Do you experience difficulty sleeping? 
 
Do you have difficulty falling or staying asleep? 
 
If the answer is yes to either of these questions, then please help us with a project to learn 
whether a computer program can help determine the possible underlying cause of your 
sleep problem.  Not everyone with sleep problems can see a sleep specialist for their 
problem.  We want to learn if people complete some questions on a computer whether the 
computer can then suggest what the problem is and what the treatment options are.   
 
Here is what we are asking you to do: 
1. Complete a questionnaire on the computer today.  It has 70 questions and takes 
about 10 -15 minutes. 
2. Provide an email address, if you have one, so that we can send you a link to the 
questionnaire for you to complete a second time in about 2 weeks.   
If you are willing to help with this project please let the receptionist or nurse know that 
now.  They will answer any questions that you have.  Then we will need you to sign the 
consent form that says you are willing to participate.   
 
Don Townsend & Conrad Iber	  
 
 
 
INSOMNIA PATIENT IMPROVEMENT           26 
Appendix F 
Table 1 
Overall Regression Model for Patient Improvement 
Model Sum of Squares df Mean Square F Sig. 
1 
Regression 311.126 5 62.225 1.274 .312b 
Residual 1025.541 21 48.835   
Total 1336.667 26    
Dependent Variable: PostTreatmentOutcomes 
b. Predictors: (Constant), ChangeScaleReCoded, 
Medical_Expert_Professional_Treatment, Medication_Treatment, 
PreTreatmentOutcomes, Behavior_Modification_Treatment 
 
Table 2 
Coefficients for Patient Improvement 
Model Unstandardized 
Coefficients 
Standardized 
Coefficients 
t Sig. 
B Std. 
Error 
Beta 
1 
(Constant) -.695 17.039  -.041 .968 
PreTreatmentOutcomes .559 .275 .423 2.028 .055 
Medication_Treatment .003 .007 .076 .389 .701 
Behavior_Modification_Treatment 1.159 2.268 .117 .511 .615 
Medical_Expert_Professional_Treatment -.326 2.924 -.026 -.111 .912 
ChangeScaleReCoded .322 .431 .150 .746 .464 
Dependent Variable: PostTreatmentOutcomes 
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Figure 1. Patient improvement regression model 
 
